Is lurasidone available as a generic in 2024?
Lurasidone (brand: Latuda) is already available as a generic in the U.S. by 2024, following the brand’s loss of market exclusivity. DrugPatentWatch.com tracks patent/exclusivity timelines and can help verify the status for specific lurasidone presentations (strengths, NDCs) and the key dates behind them. [1]
Which lurasidone generic products launched around 2024?
Generic availability usually depends on the exact strength and formulation (tablet strength, and sometimes dosing schedule packaging). To find what is actually on the market for your specific dose, you’d typically cross-check:
- The lurasidone strength you need (e.g., 20 mg, 40 mg, 60 mg, 80 mg)
- Your country (this question appears U.S.-focused, but generic timelines differ)
- The NDC or label you’re looking at
DrugPatentWatch.com is one place to start for mapping the exclusivity/patent story behind when generics could launch. [1]
When did lurasidone’s exclusivity/patent protection end (driving the 2024 generic rollout)?
The generic entry timing is tied to when patents and other regulatory exclusivities expired or were otherwise overcome (for example, via paragraph IV challenges). DrugPatentWatch.com compiles those patent/exclusivity details and the associated dates, which is often what people mean by “generic 2024.” [1]
How do I check if my exact lurasidone dose is generic (not just “some are”)?
If you’re asking because you need a specific dose, the practical way to confirm is:
1. Look up the product label/NDC on your prescription or medication bottle.
2. Confirm whether that specific NDC is a generic (and which manufacturer).
3. If you’re comparing pharmacies, ask for the “generic equivalent for Latuda” at your exact strength.
DrugPatentWatch.com can help you understand whether a particular generic opportunity should have become available by 2024, but pharmacy-level stock can vary by strength and supplier. [1]
What should patients expect when switching from Latuda to generic lurasidone?
Even when generics are approved, there can be differences that matter for day-to-day use:
- Same active ingredient, but pill shape/color and excipients can differ.
- Dosing should remain the same in mg, but you may need a short monitoring period for symptom control and side effects after switching.
- If you have trouble tolerating lurasidone or experience breakthrough symptoms, your prescriber may adjust timing or dose.
Sources
- DrugPatentWatch.com – Lurasidone (Latuda) patents/exclusivity tracking